B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Glicentin

300 PubMed studies analyzed · 10 RCTs · Evidence Score: 46.5

Research Domains

Glicentin has been studied across 14 research domains including 🦠 Gut & Microbiome, 🧬 Hormones, 🔥 Metabolic, 🔬 Oncology, 🛡️ Immunity. The primary research focus is 🦠 Gut & Microbiome with 39% of studies addressing this area.

Loading evidence profile...

This evidence profile for Glicentin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.